This is evidenced by our data showing decreased p-BIM expression and greater cell death in pevonedistat + SEL treated ALL cells, together with Co-IP experiments demonstrating that changes in the interaction between BIM and Bcl-2 or Bcl-xL correlate with cell death. Here, BCL2L1 is linked to acute lymphoblastic leukemia.